@dndi.orgDrugs for Neglected Diseases initiative (DNDi)
@dndi.org
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.
@dndi.org@dndi.org@dndi.orgHow can PDPs help shape the future of global health?
We’re co-hosting a session at #WHS2026 with partners to discuss how our model can deliver accessible health innovations in a changing global health & funding landscape.
📅 11 Oct, 16:00–17:30 CEST
Watch live: youtube.com/live/9wEMJXM...
@ghtcoalition.orgReposted by @dndi.org
@dndi.orgIndia supplies around 20% of the world’s generic medicines & is one of the largest vaccine manufacturers globally. But could it play a leading role in developing tomorrow's medicines?
Read our Asia Continental Lead Sanjay Sarin's op-ed in BusinessLine:
www.thehindubusinessline.com/specials/pul...
@bornanyaoke.bsky.socialReposted by @dndi.orgI’ll be speaking at the World Health Summit 2026 in Berlin.
📍 Workshop: Shaping the Global Health Architecture and Ending Diseases of Poverty
📅 11 October | 16:00–17:30
📌 Forum 2
#WHS2026 #GlobalHealth #Mycetoma #NTDs @dndi.org
@dndi.orgWe're proud to be recognized as a Very High Performer in the 2026 Gender & Health Index by Global Health 50/50!
We remain committed to improving gender equity both inside our organization & through our work for patients affected by neglected diseases.
Full report: global5050.org/accountabili...
@dndi.orgPleased to launch our first drug discovery partnership in Africa with KNUST. We’ll screen 100 compounds against schistosomiasis parasites, to develop the next gen of treatments while strengthening African-led drug discovery capacity. Supported by the BMFTR. www.dndi.org/press-releas...
@dndi.orgPatricia survived cryptococcal meningitis, but still lives with its consequences: the loss of her sight.
This neglected disease is preventable & treatable, yet it remains one of the leading causes of death among people living with advanced HIV.
@dndi.orgWho gets included in clinical trials matters because the treatments we develop need to reflect the needs and realities of the people who will use them.
👉 @who.int is seeking input on improving the inclusion of underrepresented populations in clinical trials: extranet.who.int/dataformv6/i...
@dndi.org🌍 But #dengue is not just a challenge for Bangladesh. Climate change, rainfall, & urbanization affect where & when outbreaks occur.
There's still no specific treatment for dengue. With millions at risk worldwide, developing one is an urgent global health priority.
@gardp.bsky.socialReposted by @dndi.org🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.
@dndi.org🌍 Getting ready for #WHS2026!
On 11 Oct, Dr Borna Nyaoke-Anoke, our Head of Mycetoma, will speak at a session to discuss the role of product development partnerships (PDPs) in advancing health equity.
🔗 Join us: worldhealthsummit.org/sessions/4f5...
@dndi.orgAt #UNGA81, our Senior Policy Advocacy Manager Rachael Crockett explains why Article 9.5 of the WHO Pandemic Agreement could be a game changer for equitable access.
🔗 Read our intervention at UNGA: dndi.org/statements/2...
@dndi.org@cepi.net @ippsecretariat.org @medicinespatentpool.org @unitaid.bsky.social @FINDdx
@dndi.orgWhat will it take to deliver therapeutics, diagnostics, & vaccines when the next outbreak hits?
At #UNGA81, Rachel Cohen highlighted 3 key priorities for pandemic R&D and access.
👉 Read the @devex.com article: www.devex.com/news/sponsor...
👉 Watch the recording: www.youtube.com/watch?v=ZZ6j...
@dndi.orgCutaneous #leishmaniasis is particularly difficult to treat in Ethiopia. A trial of thermotherapy and intralesional sodium stibogluconate found low cure rates, but thermotherapy may be a pragmatic choice when access to drugs is limited.
link.springer.com/article/10.1...
@bmc.springernature.com
@ippsecretariat.orgReposted by @dndi.orgOur first panel session is on 'Delivering the #100DaysMission: Building the Enabling Ecosystem', with insights from @dndi.org, @cepi.net and @ippsecretariat.org.
What are the capabilities, partnerships and investments needed to accelerate medical countermeasure readiness?
@dndi.org@covid-moonshot.bsky.social & @asapdiscovery.bsky.social researchers tell us how they developed innovative approaches to IP, enabling open science drug discovery while ensuring non-exclusive manufacturing & equitable access.
@healthlawadamh.bsky.socialReposted by @dndi.orgNew report worth reading from @dndi.org "Implementing Article 9.5 of the WHO #PandemicAgreement – building on current policy and practice for publicly funded R&D" dndi.org/wp-content/u...
